David A Sack

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 26

Top Venues

Microbiology spectrum

Microorganisms

PLoS neglected tropical diseases

BMJ global health

Johns Hopkins University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Johns Hopkins University

United States

Professor :: International Health

Publications

Chongyang Zhang, Siqi Li, Ipshita Upadhyay, Kathyrn L Lauder, David A Sack, Weiping Zhang
MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1-CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic Escherichia coli (ETEC). Microbiology spectrum 12 (4) (2024)
Fatema-Tuz Johura, Marzia Sultana, Abdus Sadique, Shirajum Monira, David A Sack, Richard Bradley Sack, Munirul Alam, Subhra Chakraborty
The Antimicrobial Resistance of Enterotoxigenic Escherichia coli from Diarrheal Patients and the Environment in Two Geographically Distinct Rural Areas in Bangladesh over the Years. Microorganisms 12 (2) (2024)
Chongyang Zhang, Siqi Li, Ipshita Upadhyay, Kathyrn L Lauder, David A Sack, Weiping Zhang
MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1-CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic Escherichia coli (ETEC). Microbiology spectrum 12 (4) (2024)
Chongyang Zhang, Siqi Li, Ipshita Upadhyay, Kathyrn L Lauder, David A Sack, Weiping Zhang
MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1-CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic Escherichia coli (ETEC). Microbiology spectrum (2024)
Chongyang Zhang, Siqi Li, Ipshita Upadhyay, Kathyrn L Lauder, David A Sack, Weiping Zhang
MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1-CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic Escherichia coli (ETEC). Microbiology spectrum (2024)
Fatema-Tuz Johura, Marzia Sultana, Abdus Sadique, Shirajum Monira, David A Sack, Richard Bradley Sack, Munirul Alam, Subhra Chakraborty
The Antimicrobial Resistance of Enterotoxigenic Escherichia coli from Diarrheal Patients and the Environment in Two Geographically Distinct Rural Areas in Bangladesh over the Years. Microorganisms 12 (2) (2024)
Subhra Chakraborty, Sampa Dash, Nowrin Akbar Antara, Bharati Rani Roy, Shamim Al Mamun, Mohammad Ali, Farina Naz, Fatema-Tuz Johura, Jade Lewis, Farzana Afroze, Abm Ali Hasan, David A Sack, Malathi Ram, Fahmida Tofail, Tahmeed Ahmed, Abu Syed Golam Faruque
The Impact of Non-Dysentery Shigella Infection on the Growth and Health of Children over Time (INSIGHT)-A Prospective Case-Control Study Protocol. Microorganisms 12 (8) (2024)
Chongyang Zhang, Siqi Li, Ipshita Upadhyay, Kathyrn L Lauder, David A Sack, Weiping Zhang
MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1-CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic Escherichia coli (ETEC). Microbiology spectrum (2024)
Chongyang Zhang, Siqi Li, Ipshita Upadhyay, Kathyrn L Lauder, David A Sack, Weiping Zhang
MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1-CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic Escherichia coli (ETEC). Microbiology spectrum 12 (4) (2024)
Chongyang Zhang, Siqi Li, Ipshita Upadhyay, Kathyrn L Lauder, David A Sack, Weiping Zhang
MecVax supplemented with CFA MEFA-II induces functional antibodies against 12 adhesins (CFA/I, CS1-CS7, CS12, CS14, CS17, and CS21) and 2 toxins (STa, LT) of enterotoxigenic Escherichia coli (ETEC). Microbiology spectrum 12 (4) (2024)
Ramiro L Gutiérrez, Chad K Porter, Clayton Harro, Kawsar Talaat, Mark S Riddle, Barbara DeNearing, Jessica Brubaker, Milton Maciel, Renee M Laird, Steven Poole, Subra Chakraborty, Nicole Maier, David A Sack, Stephen J Savarino
Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic Escherichia coli CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic E. coli H10407 in Healthy Adult Volunteers. Microorganisms 12 (2) (2024)
Ramiro L Gutiérrez, Chad K Porter, Clayton Harro, Kawsar Talaat, Mark S Riddle, Barbara DeNearing, Jessica Brubaker, Milton Maciel, Renee M Laird, Steven Poole, Subra Chakraborty, Nicole Maier, David A Sack, Stephen J Savarino
Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic Escherichia coli CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic E. coli H10407 in Healthy Adult Volunteers. Microorganisms 12 (2) (2024)
Nicole Maier, Shannon L Grahek, Jane Halpern, Suzanne Restrepo, Felipe Troncoso, Janet Shimko, Olga R Torres, Jaime Belkind-Gerson, David A Sack, Ann-Mari Svennerholm, Björn Gustafsson, Björn Sjöstrand, Nils Carlin, A Louis Bourgeois, Chad K Porter
Efficacy of an Enterotoxigenic Escherichia coli (ETEC) Vaccine on the Incidence and Severity of Traveler's Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity Score. Microorganisms 11 (10) (2023)
Ipshita Upadhyay, Siqi Li, Galen Ptacek, Hyesuk Seo, David A Sack, Weiping Zhang
A polyvalent multiepitope protein cross-protects against Vibrio cholerae infection in rabbit colonization and passive protection models. Proceedings of the National Academy of Sciences of the United States of America 119 (50) (2022)
Bolutife Fakoya, Karthik Hullahalli, Daniel H F Rubin, Deborah R Leitner, Roma Chilengi, David A Sack, Matthew Kaden Waldor
Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection. mBio 13 (2) (2022)
Sean Connor, Mirza Velagic, Xueyan Zhang, Fatema-Tuz Johura, Goutam Chowdhury, Asish K Mukhopadhyay, Shanta Dutta, Munirul Alam, David A Sack, Thomas F Wierzba, Subhra Chakraborty
Evaluation of a simple, rapid and field-adapted diagnostic assay for enterotoxigenic E. coli and Shigella. PLoS neglected tropical diseases 16 (2) (2022)
Christine Marie George, Tahmina Parvin, Md Sazzadul Islam Bhuyian, Ismat Minhaj Uddin, Fatema Zohura, Jahed Masud, Shirajum Monira, David A Sack, Jamie Perin, Munirul Alam, Abu Syed Golam Faruque
Randomized Controlled Trial of the Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Cholera Rapid Response Program to Reduce Diarrheal Diseases in Bangladesh. International journal of environmental research and public health 19 (19) (2022)
Irin Parvin, Abu Sadat Mohammad Sayeem Bin Shahid, Subhasish Das, Lubaba Shahrin, Mst Mahmuda Ackhter, Tahmina Alam, Soroar Hossain Khan, Mohammod Jobayer Chisti, John D Clemens, Tahmeed Ahmed, David A Sack, Abu Syed Golam Faruque
Vibrio cholerae O139 persists in Dhaka, Bangladesh since 1993. PLoS neglected tropical diseases 15 (9) (2021)
Moise Chi Ngwa, Wondimagegnehu Alemu, Ifeanyi Okudo, Collins Owili, Uzoma Ugochukwu, Peter Clement, Isabelle Devaux, Lorenzo Pezzoli, James Agada Oche, Chikwe Ihekweazu, David A Sack
The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey. BMJ global health 5 (6) (2021)
Chad K Porter, Kawsar R Talaat, Sandra D Isidean, Alwine F M Kardinaal, Subhra Chakraborty, Ramiro L Gutiérrez, David A Sack, A Louis Bourgeois
The Controlled Human Infection Model for Enterotoxigenic Escherichia coli. Current topics in microbiology and immunology (2021)
Carolina Y Garcia, Hyesuk Seo, David A Sack, Weiping Zhang
Intradermally Administered Enterotoxigenic Escherichia coli Vaccine Candidate MecVax Induces Functional Serum Immunoglobulin G Antibodies against Seven Adhesins (CFA/I and CS1 through CS6) and Both Toxins (STa and LT). Applied and environmental microbiology 88 (4) (2021)
Amanda K Debes, Allison M Shaffer, Thaddee Ndikumana, Iteka Liesse, Eric Ribaira, Clement Djumo, Mohammad Ali, David A Sack
Cholera Hot-Spots and Contextual Factors in Burundi, Planning for Elimination. Tropical medicine and infectious disease 6 (2) (2021)
Moise Chi Ngwa, Alemu Wondimagegnehu, Ifeanyi Okudo, Collins Owili, Uzoma Ugochukwu, Peter Clement, Isabelle Devaux, Lorenzo Pezzoli, Chikwe Ihekweazu, Mohammed Abba Jimme, Jeffrey G Shaffer, David A Sack
The multi-sectorial emergency response to a cholera outbreak in Internally Displaced Persons camps in Borno State, Nigeria, 2017. BMJ global health 5 (1) (2020)
Godfrey Bwire, Mellisa Roskosky, Anne Ballard, W Abdullah Brooks, Alfred Okello, Florentina Rafael, Immaculate Ampeire, Christopher Garimoi Orach, David A Sack
Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district, Uganda. BMJ open 10 (12) (2020)
K Zaman, David A Sack, Kathleen M Neuzil, Mohammad Yunus, Lawrence H Moulton, Jonathan D Sugimoto, Jessica A Fleming, Ilias Hossain, Shams El Arifeen, Tasnim Azim, Mustafizur Rahman, Kristen D C Lewis, Andrea J Feller, Firdausi Qadri, M Elizabeth Halloran, Alejandro Cravioto, John C Victor
Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial. PLoS medicine 14 (4) (2017)
Mohammad Ali, Amanda K Debes, Francisco J Luquero, Deok Ryun Kim, Je Yeon Park, Laura Digilio, Byomkesh Manna, Suman Kanungo, Shanta Dutta, Dipika Sur, Sujit K Bhattacharya, David A Sack
Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial. PLoS medicine 13 (9) (2016)

David A Sack.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David A Sack